Peptides for Brain health
The peptides people most often research for brain health, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.
- Peptides listed
- 2
- With human trials
- 2
- FDA approved (any use)
- 0
- SelankTuftsin analogHuman RCT evidence, 4 of 4Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2014, PMID 25176261Human2Animal11Summarised6Not FDA approved · research chemicalFor brain healthOverview
- SemaxACTH(4-10) analogHuman RCT evidence, 4 of 4Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2018, PMID 29798983Human13Animal53Summarised8PCAC voted 8–5 for 503A (Jul 2026)For brain healthOverview
What this list does not show
Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.
Search interest is not evidence
This list follows what people search for and discuss. It says nothing about how well any peptide works.Animal results may not carry over
Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.Approval covers specific uses
An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.Combinations are a separate question
Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.What "brain health" covers
MedlinePlus describes the brain as the control centre for thought, memory, speech and movement, and its list of common brain diseases runs from tumours to Alzheimer disease, stroke and traumatic injury.[3]
The studies below cover memory, recovery after stroke and nerve injury, rather than general sharpness.[3]
Which listed peptides have human data
Both peptides listed, Semax and Selank, have far more animal papers than human ones, and Selank has only a couple of human-only studies.
Calculated from source our PubMed count ledger ledger (PubMed title/abstract counts, 2026-10-02); selank human only 2, animal only 11, rct 1; semax human only 13, animal only 53, rct 0. Formula: Counts copied from each peptide ledger: humanOnly = human studies not also tagged animal, animalOnly = animal studies not tagged human, rct = human randomised trials. They count papers mentioning the topic, not positive results.
The strongest human result for Semax is a controlled trial in stroke patients, where plasma BDNF rose and stayed high; that is a recovery outcome in stroke, not a test in healthy people.[2]
A small neuroimaging study found a larger default mode network sub-region in the Semax group than in controls. This is an imaging measurement, not a clinical outcome.[4]
A study in rats reported that Selank increased memory trace stability over 30 days.[5]
In rats, Selank prevented memory and attention disturbances that developed during alcohol withdrawal. This is an animal finding.[6]
Related data that is not on the hub list
In a trial in early Alzheimer's disease, oral semaglutide was not efficacious in slowing clinical progression.[7]
Dihexa, a research peptide, restored spatial learning in a mouse water-maze test. No human trial is cited in the evidence file.[8]
Common questions
What peptides are good for brain health?
Only Semax has human trials cited here, and those are in stroke rehabilitation and memory disorders; the evidence for Selank comes mostly from rats.[9]
Do peptides improve cognitive function?
The cognition findings cached here come from rats or from patients who already have a disorder, and one rat study reported better retention after Semax.[10]
Is there a best peptide for brain health?
There is no head-to-head human evidence, so the cited material cannot name a best option. The human data cited are for Semax, in patients with stroke.[2]
Can peptides help with Alzheimer disease?
The only randomised Alzheimer trial in these files tested oral semaglutide and found no slowing of clinical progression.[7]
Explore nearby goals
Sources
- 1[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014PMID 25176261Accessed 2 Oct 2026
- 2[The efficacy of semax in the tretament of patients at different stages of ischemic stroke].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2018PMID 29798983Accessed 2 Oct 2026
- 3Official web pageOfficial web page · web page
- 4Effects of Semax on the Default Mode Network of the Brain.Bulletin of experimental biology and medicine · 2018PMID 30225715Accessed 2 Oct 2026
- 5[Experimental optimization of learning and memory processes by selank].Eksperimental'naia i klinicheskaia farmakologiia · 2010PMID 20919548Accessed 2 Oct 2026
- 6Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.Bulletin of experimental biology and medicine · 2019PMID 31625062Accessed 2 Oct 2026
- 7Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials.Lancet (London, England) · 2026PMID 41865758Accessed 2 Oct 2026
- 8AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway.Brain sciences · 2021PMID 34827486Accessed 2 Oct 2026
- 9[Use of semax at a follow-up of patients with posthypoxic encephalopathy].Anesteziologiia i reanimatologiia · 1999PMID 10199046Accessed 2 Oct 2026
- 10Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex.Bulletin of experimental biology and medicine · 2006PMID 17603664Accessed 2 Oct 2026
Found an error? Report a correction.